Literature DB >> 16503163

The repetitive use of samples to measure multiple cytokines: the sequential ELISA.

Marcin F Osuchowski1, Daniel G Remick.   

Abstract

The inexpensive and highly effective enzyme-linked immunosorbant assay (ELISA) is widely used for the quantification of biomarkers in a variety of biological samples. The applicability of the standard ELISA is difficult when experiments yield low volume samples. In such studies, the capacity of sample collection system does not meet the sample volume requirements to measure multiple different cytokines by the traditional ELISA protocol. In the modified methodology of the sequential ELISA, samples are re-used in multiple successive cycles, dramatically increasing the number of biomarkers which may be measured. Although the protocols presented to date were developed for quantification of cytokines in either blood plasma or cerebrospinal fluid, the sequential ELISA protocol has wide potential for further uses. When only limited quantities of samples are available for analysis, the sequential ELISA technique based on commercially available antibody pairs can be an attractive alternative to more advanced, costly multiplex methods. Additionally, any laboratory that currently runs traditional ELISAs has all the necessary equipment and reagents to perform the sequential ELISA.

Mesh:

Substances:

Year:  2006        PMID: 16503163     DOI: 10.1016/j.ymeth.2005.11.009

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  7 in total

1.  ELISA rescue protocol: recovery of sample concentrations from an assay with an unsuccessful standard curve.

Authors:  Sudha Natarajan; Daniel G Remick
Journal:  Methods       Date:  2012-09-12       Impact factor: 3.608

2.  Detection and quantification of cytokines and other biomarkers.

Authors:  Evan L Chiswick; Elizabeth Duffy; Brian Japp; Daniel Remick
Journal:  Methods Mol Biol       Date:  2012

3.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury.

Authors:  Sandra Magnoni; Thomas J Esparza; Valeria Conte; Marco Carbonara; Giorgio Carrabba; David M Holtzman; Greg J Zipfel; Nino Stocchetti; David L Brody
Journal:  Brain       Date:  2011-11-23       Impact factor: 13.501

4.  Cecal ligation and puncture-induced murine sepsis does not cause lung injury.

Authors:  Kendra N Iskander; Florin L Craciun; David M Stepien; Elizabeth R Duffy; Jiyoun Kim; Rituparna Moitra; Louis J Vaickus; Marcin F Osuchowski; Daniel G Remick
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

5.  High throughput sequential ELISA for validation of biomarkers of acute graft-versus-host disease.

Authors:  Bryan Fiema; Andrew C Harris; Aurelie Gomez; Praechompoo Pongtornpipat; Kelly Lamiman; Mark T Vander Lugt; Sophie Paczesny
Journal:  J Vis Exp       Date:  2012-10-31       Impact factor: 1.355

Review 6.  Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.

Authors:  Samantha Spindel; Kim E Sapsford
Journal:  Sensors (Basel)       Date:  2014-11-25       Impact factor: 3.576

7.  Evaluation of the gut microbiome in association with biological signatures of inflammation in murine polytrauma and shock.

Authors:  Sandra A Appiah; Christine L Foxx; Dominik Langgartner; Christopher A Lowry; Rebecca Halbgebauer; Annette Palmer; Cristian A Zambrano; Sonja Braumüller; Evan J Schaefer; Ulrich Wachter; Brooke L Elam; Peter Radermacher; Christopher E Stamper; Jared D Heinze; Stephanie N Salazar; Amalia K Luthens; Andrea L Arnold; Stefan O Reber; Markus Huber-Lang
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.